Use of herbal medicine by caregivers in the management of children with sickle cell disease in Mulago National Referral Hospital - Uganda
- PMID: 34548892
- PMCID: PMC8435373
- DOI: 10.11604/pamj.2021.39.163.20740
Use of herbal medicine by caregivers in the management of children with sickle cell disease in Mulago National Referral Hospital - Uganda
Abstract
Introduction: Sickle Cell Disease (SCD) is the leading genetic disease in sub-Saharan Africa and therefore remains a global public health threat. Use of complementary and alternative medicines (CAM) most especially herbal medicine (HM) in chronic diseases such as sickle cell disease has widely been reported in Africa where advanced technologies are greatly lacking. Despite a large presence of the sickle cell disease in Uganda, the extent to which herbal medicines are used in management of children with sickle cell disease has not been documented. This study purposed to determine the prevalence of herbal medicine (HM) use and associated factors among caregivers of children with SCD at Mulago National Referral Hospital.
Methods: a total of 384 child caretakers were interviewed in a descriptive cross-sectional quantitative study conducted at the Mulago Sickle cell clinic in March 2019. Enrolment was done consecutively and a structured interviewer administered questionnaire administered to collect data from the caretakers which was managed using SPSS version 23. Multivariate logistic regression was used to identify the factors associated with herbal medicine (HM) use. Factors with p-value <0.05 were regarded significant.
Results: the rate of herbal use was 77.6% (298 of 384 caregivers). At multivariate analysis, the odds of a caregiver who agreed that; HM cures symptoms faster than conventional medicine (CM) were 3 times those who disagreed with this statement (AOR =3.439, 95% CI: 1.447 - 8.176). The odds that a caregiver who agreed that HM has fewer side effects than CM were almost 4 times those that disagreed with this statement (AOR = 3.528, 95% CI: 1.917 -6.494). The odds that a caregiver who agreed that marketing HM through televisions adverts encourages HM use were 4 times those who disagreed with this statement (AOR = 4.185, 95% CI: 2.036 -8.603).
Conclusion: this study reports a high prevalence of HM use among caregivers of children with SCD at Mulago Hospital, in Uganda. The practice is significantly influenced by caretakers´ perception that HM cures symptoms faster than CM, has fewer side effects and that telemarketing has greatly facilitated its use over CM. More effort is therefore needed to encourage clinic attendances and CM use and limit the unfounded TV adverts on HM. There is also need for studies to identify the common HM used so that their efficacy and safety are well studied.
Keywords: Herbal medicine; caregivers; use.
Copyright: Martin Lubega et al.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Caregivers' use of herbal and conventional medicine to treat children with sickle cell disease at Jinja Regional Referral Hospital, Eastern Uganda: A cross-sectional study.PLoS One. 2023 Sep 8;18(9):e0291008. doi: 10.1371/journal.pone.0291008. eCollection 2023. PLoS One. 2023. PMID: 37682924 Free PMC article.
-
Understanding patient-related barriers to hydroxyurea use among adolescent and adult patients with sickle cell disease in Mulago and Kiruddu hospitals, Uganda, a qualitative study.BMC Health Serv Res. 2024 May 27;24(1):666. doi: 10.1186/s12913-024-11125-6. BMC Health Serv Res. 2024. PMID: 38802815 Free PMC article.
-
Prevalence and factors associated with hypothyroidism in children with sickle cell anemia aged 6 months - 17 years attending the Sickle Cell Clinic, Mulago Hospital, Uganda; a cross-sectional study.BMC Endocr Disord. 2023 Mar 13;23(1):60. doi: 10.1186/s12902-023-01317-2. BMC Endocr Disord. 2023. PMID: 36907861 Free PMC article.
-
Herbal Medicines: challenges in the modern world. Part 5. status and current directions of complementary and alternative herbal medicine worldwide.Expert Rev Clin Pharmacol. 2017 Mar;10(3):327-338. doi: 10.1080/17512433.2017.1268917. Epub 2016 Dec 15. Expert Rev Clin Pharmacol. 2017. PMID: 27923318 Review.
-
Herbal Drug use in Sickle Cell Disease Management; Trends and Perspectives in Sub-Saharan Africa - A Systematic Review.Curr Drug Discov Technol. 2019;16(4):372-385. doi: 10.2174/1570163815666181002101611. Curr Drug Discov Technol. 2019. PMID: 30277160
Cited by
-
"We Cure Sickle Cell Disease with Herbs": Perspectives of Herbal Medicine Practitioners Treating Sickle Cell Disease in the Acholi Sub-Region.J Multidiscip Healthc. 2025 Jul 28;18:4267-4277. doi: 10.2147/JMDH.S534707. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40756612 Free PMC article.
-
Penicillin V prophylaxis uptake among children living with sickle cell disease in a specialist sickle cell clinic in Ghana: A cross-sectional study.Health Sci Rep. 2022 Nov 24;5(6):e953. doi: 10.1002/hsr2.953. eCollection 2022 Nov. Health Sci Rep. 2022. PMID: 36439045 Free PMC article.
-
Caregivers' use of herbal and conventional medicine to treat children with sickle cell disease at Jinja Regional Referral Hospital, Eastern Uganda: A cross-sectional study.PLoS One. 2023 Sep 8;18(9):e0291008. doi: 10.1371/journal.pone.0291008. eCollection 2023. PLoS One. 2023. PMID: 37682924 Free PMC article.
-
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.medRxiv [Preprint]. 2024 Jan 13:2024.01.12.24301208. doi: 10.1101/2024.01.12.24301208. medRxiv. 2024. Update in: Contemp Clin Trials Commun. 2024 Nov 28;42:101404. doi: 10.1016/j.conctc.2024.101404. PMID: 38260320 Free PMC article. Updated. Preprint.
-
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.Contemp Clin Trials Commun. 2024 Nov 28;42:101404. doi: 10.1016/j.conctc.2024.101404. eCollection 2024 Dec. Contemp Clin Trials Commun. 2024. PMID: 39717517 Free PMC article.
References
-
- Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study. Lancet Glob Heal. 2016;4(3):e195–e200. - PubMed
-
- WHO Africa RC for A Sickle cell disease: a strategy for the WHO African Region-Regional Committee for Africa, AFR/RC60/8. Malabo, equatorial guinea. 2010;Vol.6(Sept):1–9.
-
- Cırık V, Efe E. The use of complementary and alternative medicine by children. J Family Med Community Health. 2015;2(2):1031.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical